RAMPs as drug targets

Patrick M Sexton, David R Poyner, John Simms, Arthur Christopoulos, Debbie L Hay

Research output: Chapter in Book/Report/Conference proceedingChapter

9 Citations (Scopus)

Abstract

The receptor activity-modifying protein (RAMP) family of membrane proteins regulates G protein-coupled receptor (GPCR) function in several ways. RAMPs can alter their pharmacology and signalling as well as the trafficking of these receptors to and from the cell surface. Accordingly, RAMPs may be exploited as drug targets, offering new opportunities for regulating the function of therapeutically relevant RAMP-interacting GPCRs. For example, several small molecule antagonists of RAMP1/ calcitonin receptor-like receptor complexes, which block the actions of the neuropeptide calcitonin gene-related peptide are in development for the treatment of migraine headache.

Original languageEnglish
Title of host publicationRAMPS
EditorsWilliam S. Spielman, Narayanan Parameswaran
PublisherSpringer
Pages61-74
Number of pages14
ISBN (Electronic)9781461423638
DOIs
Publication statusPublished - 2012

Publication series

NameAdvances in Experimental Medicine and Biology
PublisherSpringer
Volume744

Fingerprint

Receptor Activity-Modifying Proteins
Calcitonin Receptor-Like Protein
Calcitonin Gene-Related Peptide
Cell Surface Receptors
G-Protein-Coupled Receptors
Neuropeptides
Migraine Disorders
Pharmaceutical Preparations
Membrane Proteins
Pharmacology

Keywords

  • Receptor Activity-Modifying Proteins
  • Receptors, G-Protein-Coupled
  • Signal Transduction
  • Journal Article
  • Review

Cite this

Sexton, P. M., Poyner, D. R., Simms, J., Christopoulos, A., & Hay, D. L. (2012). RAMPs as drug targets. In W. S. Spielman, & N. Parameswaran (Eds.), RAMPS (pp. 61-74). (Advances in Experimental Medicine and Biology; Vol. 744). Springer. https://doi.org/10.1007/978-1-4614-2364-5_6

RAMPs as drug targets. / Sexton, Patrick M; Poyner, David R; Simms, John; Christopoulos, Arthur; Hay, Debbie L.

RAMPS. ed. / William S. Spielman; Narayanan Parameswaran. Springer, 2012. p. 61-74 (Advances in Experimental Medicine and Biology; Vol. 744).

Research output: Chapter in Book/Report/Conference proceedingChapter

Sexton, PM, Poyner, DR, Simms, J, Christopoulos, A & Hay, DL 2012, RAMPs as drug targets. in WS Spielman & N Parameswaran (eds), RAMPS. Advances in Experimental Medicine and Biology, vol. 744, Springer, pp. 61-74. https://doi.org/10.1007/978-1-4614-2364-5_6
Sexton PM, Poyner DR, Simms J, Christopoulos A, Hay DL. RAMPs as drug targets. In Spielman WS, Parameswaran N, editors, RAMPS. Springer. 2012. p. 61-74. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-1-4614-2364-5_6
Sexton, Patrick M ; Poyner, David R ; Simms, John ; Christopoulos, Arthur ; Hay, Debbie L. / RAMPs as drug targets. RAMPS. editor / William S. Spielman ; Narayanan Parameswaran. Springer, 2012. pp. 61-74 (Advances in Experimental Medicine and Biology).
@inbook{6456403225814df08a01f6fbe411ee00,
title = "RAMPs as drug targets",
abstract = "The receptor activity-modifying protein (RAMP) family of membrane proteins regulates G protein-coupled receptor (GPCR) function in several ways. RAMPs can alter their pharmacology and signalling as well as the trafficking of these receptors to and from the cell surface. Accordingly, RAMPs may be exploited as drug targets, offering new opportunities for regulating the function of therapeutically relevant RAMP-interacting GPCRs. For example, several small molecule antagonists of RAMP1/ calcitonin receptor-like receptor complexes, which block the actions of the neuropeptide calcitonin gene-related peptide are in development for the treatment of migraine headache.",
keywords = "Receptor Activity-Modifying Proteins, Receptors, G-Protein-Coupled, Signal Transduction, Journal Article, Review",
author = "Sexton, {Patrick M} and Poyner, {David R} and John Simms and Arthur Christopoulos and Hay, {Debbie L}",
year = "2012",
doi = "10.1007/978-1-4614-2364-5_6",
language = "English",
series = "Advances in Experimental Medicine and Biology",
publisher = "Springer",
pages = "61--74",
editor = "Spielman, {William S. } and Parameswaran, {Narayanan }",
booktitle = "RAMPS",

}

TY - CHAP

T1 - RAMPs as drug targets

AU - Sexton, Patrick M

AU - Poyner, David R

AU - Simms, John

AU - Christopoulos, Arthur

AU - Hay, Debbie L

PY - 2012

Y1 - 2012

N2 - The receptor activity-modifying protein (RAMP) family of membrane proteins regulates G protein-coupled receptor (GPCR) function in several ways. RAMPs can alter their pharmacology and signalling as well as the trafficking of these receptors to and from the cell surface. Accordingly, RAMPs may be exploited as drug targets, offering new opportunities for regulating the function of therapeutically relevant RAMP-interacting GPCRs. For example, several small molecule antagonists of RAMP1/ calcitonin receptor-like receptor complexes, which block the actions of the neuropeptide calcitonin gene-related peptide are in development for the treatment of migraine headache.

AB - The receptor activity-modifying protein (RAMP) family of membrane proteins regulates G protein-coupled receptor (GPCR) function in several ways. RAMPs can alter their pharmacology and signalling as well as the trafficking of these receptors to and from the cell surface. Accordingly, RAMPs may be exploited as drug targets, offering new opportunities for regulating the function of therapeutically relevant RAMP-interacting GPCRs. For example, several small molecule antagonists of RAMP1/ calcitonin receptor-like receptor complexes, which block the actions of the neuropeptide calcitonin gene-related peptide are in development for the treatment of migraine headache.

KW - Receptor Activity-Modifying Proteins

KW - Receptors, G-Protein-Coupled

KW - Signal Transduction

KW - Journal Article

KW - Review

U2 - 10.1007/978-1-4614-2364-5_6

DO - 10.1007/978-1-4614-2364-5_6

M3 - Chapter

T3 - Advances in Experimental Medicine and Biology

SP - 61

EP - 74

BT - RAMPS

A2 - Spielman, William S.

A2 - Parameswaran, Narayanan

PB - Springer

ER -